The effect of sodium valproate on plasma ACTH and cortisol concentrations in Cushing's disease and Nelson's syndrome.
Kasperlik-Załuska
A
A
Drac-Kaniewska
J
J
Migdalska
B
B
Jeske
W
W
Wiśniewska-Woźniak
T
T
D000324:Adrenocorticotropic Hormone / Q000037:antagonists & inhibitors / Q000097:blood*; D000328:Adult; D003480:Cushing Syndrome / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006727:Hormone Antagonists; D006801:Humans; D006854:Hydrocortisone / Q000037:antagonists & inhibitors / Q000097:blood*; D008875:Middle Aged; D009347:Nelson Syndrome / Q000097:blood / Q000188:drug therapy*; D010911:Pituitary Neoplasms / Q000188:drug therapy*; D012074:Remission Induction; D014635:Valproic Acid / Q000627:therapeutic use*
D006727:Hormone Antagonists; D014635:Valproic Acid; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone